ADGI - Adagio Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Adagio Therapeutics's activity chart (see below) currently has 7 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.9% with an average time for these price targets to be met of 18.14 days.

Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 17-May-2022. First documented stock forecast 31-Aug-2021.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell Since 07-Jan-2022

$-0.48 (-13.79%)

Hold Since 13-May-2022

$1.52 (43.68%)

Hold Since 23-Dec-2021

$10

$6.52 (187.36%)

Hold Since 16-Dec-2021

$40

Show more analysts

What is ADGI (Adagio Therapeutics) average time for price targets to be met?

On average it took 18.14 days on average for the stock forecasts to be realized with a an average price target met ratio 61.9

Which analyst has the current highest performing score on ADGI (Adagio Therapeutics) with a proven track record?

MICHAEL YEE

Which analyst has the most public recommendations on ADGI (Adagio Therapeutics)?

Michael Yee works at UBS and has 7 price targets and 10 ratings on ADGI

Which analyst is the currently most bullish on ADGI (Adagio Therapeutics)?

Michael Yee with highest potential upside - $6.52

Which analyst is the currently most reserved on ADGI (Adagio Therapeutics)?

Matthew Harrison with lowest potential downside - -$0.48